A gene-based blood test works as well as a routine biopsy to help heart transplant recipients to avoid serious complications of the transplant surgery, including death, a second transplant or heart-failure symptoms from organ rejections, according to a new study. In the study, researchers reported a simple blood test called AlloMap, created by the molecular [Sign in to read the full article...]